REXAHN PHARMACEUTICALS INC's ticker is RNN and the CUSIP is 761640101. A total of 35 filers reported holding REXAHN PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Northeast Financial Consultants Inc | 150,000 | $130,000 | 0.07% |
| Benin Management CORP | 83,000 | $72,000 | 0.04% |
| CONDOR CAPITAL MANAGEMENT | 114,987 | $100,000 | 0.03% |
| FIRST NEW YORK SECURITIES LLC /NY | 15,000 | $13,050,000 | 0.01% |
| Advisory Services Network, LLC | 22,000 | $19,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 180,000 | $157,000 | 0.00% |
| Moors & Cabot, Inc. | 25,000 | $22,000 | 0.00% |
| Corbenic Partners LLC | 1,600 | $1,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 4,566 | $4,000 | 0.00% |
| AQR Capital Management | 213,900 | $186,000 | 0.00% |